Immuneering Corp. Class A IMRX
NASDAQ · United States · Health Technology
$4.07+0.04 (+0.99%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.27 | -0.27 | -0.5% | $0 | — | +2.7%$4.39→$4.51 |
| Q1 2026 | 2026-05-15 | -0.21 | -0.25 | +16.0% | — | — | -5.3%$5.14→$4.87 |
| Q4 2025 | 2026-03-06 | -0.18 | -0.31 | +41.9% | — | — | +12.9%$4.98→$5.62 |
| Q3 2025 | 2025-11-12 | -0.38 | -0.39 | +2.6% | — | — | -4.3%$6.74→$6.45 |
| Q2 2025 | 2025-08-13 | -0.40 | -0.40 | 0.0% | — | — | — |
| Q1 2025 | 2025-05-05 | -0.42 | -0.58 | +27.6% | — | — | — |
| Q4 2024 | 2025-03-20 | -0.58 | -0.44 | -31.8% | — | — | — |
| Q3 2024 | 2024-11-13 | -0.49 | -0.55 | +10.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.